SCHEMBL10069070

SCHEMBL10069070

CC(=O)c1ccc(NC(=O)Nc2cccc(S)c2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.72
TP53 P04637 4/20 0.72
KMT2A Q03164 8/20 0.68
RAB9A P51151 7/20 0.68
NPC1 O15118 7/20 0.68
MAPT P10636 6/20 0.68
MEN1 O00255 6/20 0.68
SMN1; SMN2 Q16637 4/20 0.68
TAAR1 Q96RJ0 1/20 0.68
CA12 O43570 3/20 0.62
CA1 P00915 3/20 0.62
CA2 P00918 3/20 0.62
CA9 Q16790 3/20 0.62
HTT P42858 4/20 0.57
NLRP1 Q9C000 1/20 0.57
POLB P06746 2/20 0.56
MAPK1 P28482 2/20 0.56
MCL1 Q07820 2/20 0.56
NOX1 Q9Y5S8 2/20 0.56
USP2 O75604 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22588860 0.83 ALDH1A1 (0.74) ALDH1A1TP53KMT2ARAB9ANPC1
SCHEMBL4113285 0.83 NPC1 (0.74) ALDH1A1TP53KMT2ARAB9ANPC1
SCHEMBL1719786 0.81 RAB9A (1.00) ALDH1A1TP53KMT2ARAB9ANPC1
SCHEMBL29285315 0.81 ALDH1A1 (0.72) ALDH1A1TP53KMT2ARAB9ANPC1
SCHEMBL4112319 0.81 ALDH1A1 (0.72) ALDH1A1TP53KMT2ARAB9ANPC1
SCHEMBL4105400 0.81 RAB9A (0.74) ALDH1A1TP53KMT2ARAB9ANPC1
SCHEMBL4106827 0.81 MEN1 (1.00) ALDH1A1TP53KMT2ARAB9ANPC1
SCHEMBL30987791 0.81 ALDH1A1 (0.72) ALDH1A1TP53KMT2ARAB9ANPC1
SCHEMBL3633396 0.81 NPC1 (0.84) ALDH1A1TP53KMT2ARAB9ANPC1
SCHEMBL10069138 0.81 CA12 (0.60) ALDH1A1TP53KMT2ARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012021963-A1 NOVEL SULFONAMIDE COMPOUNDS FOR INHIBITION OF METASTATIC TUMOR GROWTH METASIGNAL THERAPEUTICS INC. (CA) 2012-02-23 WO disclosed